| Product Information |
DR-XY48675_PI_01.pdf
|
| Registration Number |
DR-XY48675
|
| Generic Name |
Ibrutinib
|
| Brand Name |
Imbruvica
|
| Dosage Strength |
140 mg
|
| Dosage Form |
Film-Coated Tablet
|
| Classification |
Prescription Drug (RX)
|
| Pharmacologic Category |
Antineoplastic Agent (Protein Kinase Inhibitor)
|
| Packaging |
PVC/PCTFE/Alu Blister Pack x 14’s
|
| Manufacturer |
Cilag AG
|
| Country of Origin |
Switzerland
|
| Trader |
N/A
|
| Importer |
Johnson & Johnson (Philippines), Inc.
|
| Distributor |
|
| Application Type |
Monitored Release (Correction)
|
| Issuance Date |
28 September 2023
|
| Expiry Date |
30 March 2028
|